An update to the American Radium Society's appropriate use criteria of lower grade gliomas: Integration of IDH inhibitors

Tom, M. C., Nagpal, S., Palmer, J. D., Breen, W. G., Pollom, E. L., Lehrer, E. J., McGranahan, T. M., Shiue, K., Chundury, A., McClelland III, S., Saeed, H., Chang, E. L., Chiang, V. L. S., Wang, T. J. C., Knisely, J. P. S., Chao, S. T., & Milano, M. T. (2025). An update to the American Radium Society’s appropriate use criteria of lower grade gliomas: Integration of IDH inhibitors. Radiotherapy and Oncology, 202, 110640. https://doi.org/10.1016/j.radonc.2024.110640
Authors:
Martin C Tom
Seema Nagpal
Joshua D Palmer
William G Breen
Erqi L Pollom
Eric J Lehrer
Tresa M McGranahan
Kevin Shiue
Anupama Chundury
Shearwood McClelland Iii
Hina Saeed
Eric L Chang
Veronica L S Chiang
Tony J C Wang
Jonathan P S Knisely
Samuel T Chao
Michael T Milano
Affiliated Authors:
Tony J C Wang
Author Keywords:
astrocytoma
grade 2 glioma
idh inhibitor
oligodendroglioma
vorasidenib
Publication Type:
Article
Unique ID:
10.1016/j.radonc.2024.110640
PMID:
Publication Date:
Data Source:
PubMed

Record Created: